Connect with us
ACS Biotech has developed a unique gel in the world capable of repairing cartilage damage occurring following traumatic shock or a degenerative disease such as osteoarthritis....
Cure51 secured funding in a round led by Sofinnova Partners, joined by Hitachi Ventures, Xavier Niel, and others. The company aims to investigate molecular processes enabling...
In detail, this new financing was led by Sofinnova Partners and co-managed by Intermediate Capital Group, but the transaction also benefited from the participation of historical...